{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:09:07Z","timestamp":1788268147509,"version":"build-2803163510"},"reference-count":24,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2024,5,28]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Primary outcome measure in the clinical trials of disease modifying therapy (DMT) drugs for Alzheimer\u2019s disease (AD) has often been evaluated by Clinical Dementia Rating sum of boxes (CDRSB). However, CDR testing requires specialized training and 30\u201350 minutes to complete, not being suitable for daily clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Herein, we proposed a machine-learning method to estimate CDRSB changes using simpler cognitive\/functional batteries (Mini-Mental State Examination [MMSE] and Functional Activities Questionnaire [FAQ]), to replace CDR testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Baseline data from 944 ADNI and 171 J-ADNI amyloid-positive participants were used to build machine-learning models predicting annualized CDRSB changes between visits, based on MMSE and FAQ scores. Prediction performance was evaluated with mean absolute error (MAE) and R\n                      <jats:sup>2<\/jats:sup>\n                      comparing predicted to actual rmDeltaCDRSB\/rmDeltayear. We further assessed whether decline in cognitive function surpassing particular thresholds could be identified using the predicted rmDeltaCDRSB\/rmDeltayear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The models achieved the minimum required prediction errors (MAE\u200a&lt;\u200a1.0) and satisfactory prediction accuracy (R\n                      <jats:sup>2<\/jats:sup>\n                      &gt;0.5) for mild cognitive impairment (MCI) patients for changes in CDRSB over periods of 18 months or longer. Predictions of annualized CDRSB progression&gt;0.5, &gt;1.0, or &gt;1.5 demonstrated a consistent performance (i.e., Matthews correlation coefficient&gt;0.5). These results were largely replicated in the J-ADNI case predictions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our method effectively predicted MCI patient deterioration in the CDRSB based solely on MMSE and FAQ scores. It may aid routine practice for disease-modifying therapy drug efficacy evaluation, without necessitating CDR testing at every visit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jad-231426","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T10:58:36Z","timestamp":1715684316000},"page":"953-963","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Simplifying Alzheimer\u2019s Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire"],"prefix":"10.1177","volume":"99","author":[{"given":"Kenichiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan"},{"name":"Department of Healthcare Economics and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Neurology, Internal Medicine, National Defense Medical College, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Iwatsubo","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Japanese Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,5,11]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12385"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212948"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"ref005","first-page":"362","volume":"10","author":"Cummings J","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"ref006","unstructured":"Eisai. \u201cLEQEMBI\n                      \u00ae\n                      Intous Infusion\u201d (Lecanemab) Approved for the Treatment of Alzheimer\u2019s Disease in Japan, https:\/\/www.eisai.com\/news\/2023\/news202359.html, Accessed on September 25, 2023."},{"key":"ref007","unstructured":"Biogen. \u201cLEQEMBI\n                      \u00ae\n                      \u201d (Lecanemab) Approved for the Treatment of Alzheimer\u2019s Disease in China, https:\/\/investors.biogen.com\/news-releases\/news-release-details\/leqembir-lecanemab-approved-treatment-alzheimers-disease-china, Accessed on January 9, 2024."},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51880"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12377"},{"key":"ref010","first-page":"211","volume":"9","author":"Barakos J","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2015.05.014"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.33786"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cb3e25"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.03.009"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21610"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100988"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.9"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2019.06.005"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6413-7"},{"key":"ref021","unstructured":"Ministry of Health, Labour, and Welfare. Optimal Use Guideline for lecanemab, https:\/\/www.mhlw.go.jp\/content\/12404000\/001178607.pdf, Accessed on December 13, 2023."},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2019.06.004"},{"key":"ref024","unstructured":"Central Social Insurance Medical Council. Responses to high-cost drugs (for dementia): resources submitted on October 18, 2023, https:\/\/www.mhlw.go.jp\/content\/12404000\/001157647.pdf, Accessed on December 13, 2023."}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-231426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-231426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-231426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:39Z","timestamp":1777370919000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-231426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5,28]]}},"alternative-id":["10.3233\/JAD-231426"],"URL":"https:\/\/doi.org\/10.3233\/jad-231426","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,11]]}}}